Concord Biotech Limited

NSE: CONCORDBIO INE338H01029 Healthcare

₹1,230.60

-2.99% · close 29 Oct 2026

P/E (TTM)

43.7

52W high

₹1,587.50

52W low

₹1,014.80

1Y return

-15.28%

Turnover

₹22 Cr

Concord Biotech Limited (CONCORDBIO) closed at ₹1,230.60 on 29 Oct 2026, down 2.99% on the day. The share price fell 15.3% over the past year (adjusted for splits and bonuses) and sits 22.5% below its 52-week high of ₹1,587.50. In the Sept 2026 quarter, revenue rose 26.3% year on year to ₹312 Cr and net profit rose 20.6% to ₹76 Cr.

Source: Indian Stock API, from company filings. Annual columns are financial years; TTM is the trailing twelve months.